Compagnie Lombard Odier SCmA’s NanoViricides NNVC Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-200,000	Closed	-$273K	–	487
2025 Q1	$234K	Buy	200,000 +50,000	+33%	+$63.5K	﹤0.01%	248
2024 Q4	$215K	Hold	150,000	–	–	﹤0.01%	237
2024 Q3	$225K	Hold	150,000	–	–	﹤0.01%	235
2024 Q2	$258K	Hold	150,000	–	–	﹤0.01%	220
2024 Q1	$174K	Hold	150,000	–	–	﹤0.01%	273
2023 Q4	$153K	Hold	150,000	–	–	﹤0.01%	314
2023 Q3	$201K	Hold	150,000	–	–	﹤0.01%	267
2023 Q2	$173K	Hold	150,000	–	–	﹤0.01%	290
2023 Q1	$176K	Hold	150,000	–	–	﹤0.01%	311
2022 Q4	$166K	Hold	150,000	–	–	﹤0.01%	315
2022 Q3	$259K	Hold	150,000	–	–	0.01%	271
2022 Q2	$282K	Hold	150,000	–	–	0.01%	251
2022 Q1	$314K	Buy	150,000 +80,000	+114%	+$187K	0.01%	257
2021 Q4	$260K	Hold	70,000	–	–	0.01%	324
2021 Q3	$325K	Buy	70,000 +10,000	+17%	+$41.7K	0.01%	297
2021 Q2	$278K	Buy	60,000 +20,000	+50%	+$80.7K	0.01%	301
2021 Q1	$189K	Buy	+40,000	New	+$181K	﹤0.01%	393

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Compagnie Lombard Odier SCmA's NNVC Position: Q2 2025 in Review

Compagnie Lombard Odier SCmA sold out of NanoViricides (NNVC) in Q2 2025, closing a stake of 200,000 shares — an estimated $273K sold.

Compagnie Lombard Odier SCmA first reported a position in NNVC in Q1 2021 and held it in 17 quarters. The position peaked at $325K in Q3 2021. 33 funds tracked by Wall St. Rank hold NNVC as of Q2 2025.

Compagnie Lombard Odier SCmA reported no remaining NanoViricides position as of Q2 2025 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 200,000 NanoViricides shares in Q2 2025, an estimated $273K.
Compagnie Lombard Odier SCmA first reported a position in NanoViricides in Q1 2021 and held it in 17 quarters.
Compagnie Lombard Odier SCmA's NanoViricides position peaked at $325K in Q3 2021.
33 funds tracked by Wall St. Rank held NanoViricides as of Q2 2025.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2025, filed 15 Jul 2025.